Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tzu-Fei Wang

Showing results (1-10 of 152) with videos related to

Pageof 16
Sort By:
Research and Practice in Thrombosis and Haemostasis|July 25, 2025
To anticoagulate or not to anticoagulate-that is the question in patients with fall risksTzu-Fei Wang
JACC. Cardiooncology|January 13, 2025
The Rise and Fall of C-Reactive Protein: Can it Predict Immune Checkpoint Inhibitor-Associated Venous Thromboembolism?Tzu-Fei Wang
Thrombosis Research|October 10, 2022
Drug-drug interactions: Implications for anticoagulation, with focus in patients with cancerTzu-Fei Wang
Journal of Thrombosis and Haemostasis : JTH|October 20, 2021
Survival in patients with cancer-associated thrombosis in relation to anticoagulants: Re-vitalization of warfarin?Tzu-Fei Wang
Hematology. American Society of Hematology. Education Program|December 4, 2016
What is the role of hydroxychloroquine in reducing thrombotic risk in patients with antiphospholipid antibodies?Tzu-Fei Wang, Wendy Lim
Blood|January 25, 2020
How I treat obese patients with oral anticoagulantsTzu-Fei Wang, Marc Carrier
Blood|June 24, 2020
Direct oral anticoagulants and cancer-associated VTE: good for all, or just some?Marc Carrier, Tzu-Fei Wang
British Journal of Haematology|May 13, 2020
Thromboprophylaxis in patients with multiple myelomaTzu-Fei Wang, Aurélien Delluc
Current Oncology (Toronto, Ont.)|March 28, 2023
Immune Checkpoint Inhibitors-Associated Thrombosis: Incidence, Risk Factors and ManagementTzu-Fei Wang, Marc Carrier
Hematology. American Society of Hematology. Education Program|December 9, 2022
The 5 most frequently asked questions about factor Xa inhibitorsTzu-Fei Wang, Marc Carrier
Pageof 16

Showing results (1-10 of 152) with videos related to

Sort By:
Pageof 16
Research and Practice in Thrombosis and Haemostasis|July 25, 2025
To anticoagulate or not to anticoagulate-that is the question in patients with fall risksTzu-Fei Wang
JACC. Cardiooncology|January 13, 2025
The Rise and Fall of C-Reactive Protein: Can it Predict Immune Checkpoint Inhibitor-Associated Venous Thromboembolism?Tzu-Fei Wang
Thrombosis Research|October 10, 2022
Drug-drug interactions: Implications for anticoagulation, with focus in patients with cancerTzu-Fei Wang
Journal of Thrombosis and Haemostasis : JTH|October 20, 2021
Survival in patients with cancer-associated thrombosis in relation to anticoagulants: Re-vitalization of warfarin?Tzu-Fei Wang
Hematology. American Society of Hematology. Education Program|December 4, 2016
What is the role of hydroxychloroquine in reducing thrombotic risk in patients with antiphospholipid antibodies?Tzu-Fei Wang, Wendy Lim
Blood|January 25, 2020
How I treat obese patients with oral anticoagulantsTzu-Fei Wang, Marc Carrier
Blood|June 24, 2020
Direct oral anticoagulants and cancer-associated VTE: good for all, or just some?Marc Carrier, Tzu-Fei Wang
British Journal of Haematology|May 13, 2020
Thromboprophylaxis in patients with multiple myelomaTzu-Fei Wang, Aurélien Delluc
Current Oncology (Toronto, Ont.)|March 28, 2023
Immune Checkpoint Inhibitors-Associated Thrombosis: Incidence, Risk Factors and ManagementTzu-Fei Wang, Marc Carrier
Hematology. American Society of Hematology. Education Program|December 9, 2022
The 5 most frequently asked questions about factor Xa inhibitorsTzu-Fei Wang, Marc Carrier
Pageof 16